Publication:
Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021

Simple item page
dc.contributor.authorMazagatos, Clara
dc.contributor.authorMonge Corella, Susana
dc.contributor.authorOlmedo, Carmen
dc.contributor.authorVega-Piris, Lorena
dc.contributor.authorGallego Berciano, Pilar
dc.contributor.authorMartín-Merino, Elisa
dc.contributor.authorSierra, María José
dc.contributor.authorLimia, Aurora
dc.contributor.authorLarrauri, Amparo
dc.contributor.authorWorking group for the surveillance and control of COVID-19 in Spain
dc.date.accessioned2022-04-07T09:24:19Z
dc.date.available2022-04-07T09:24:19Z
dc.date.issued2021
dc.description.abstractResidents in long-term care facilities (LTCF) experienced a large morbidity and mortality during the COVID-19 pandemic in Spain and were prioritised for early COVID-19 vaccination. We used the screening method and population-based data sources to obtain estimates of mRNA COVID-19 vaccine effectiveness for elderly LTCF residents. The estimates were 71% (95% CI: 56-82%), 88% (95% CI: 75-95%), and 97% (95% CI: 92-99%), against SARS-CoV-2 infections (symptomatic and asymptomatic), and COVID-19 hospitalisations and deaths, respectively.es_ES
dc.description.peerreviewedSíes_ES
dc.format.number24es_ES
dc.format.volume26es_ES
dc.identifier.citationEuro Surveill. 2021;26(24).es_ES
dc.identifier.doi10.2807/1560-7917.ES.2021.26.24.2100452es_ES
dc.identifier.e-issn1560-7917es_ES
dc.identifier.journalEuro Surveillancees_ES
dc.identifier.pubmedID34142647es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/13943
dc.language.isoenges_ES
dc.publisherEuropean Centre for Disease Prevention and Control (ECDC)
dc.relation.publisherversionhttps://doi.org/10.2807/1560-7917.ES.2021.26.24.2100452es_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCOVID-19es_ES
dc.subjectLTCFes_ES
dc.subjectScreeninges_ES
dc.subjectSurveillancees_ES
dc.subjectVaccinationes_ES
dc.subject.meshCOVID-19es_ES
dc.subject.meshCOVID-19 Vaccineses_ES
dc.subject.meshAgedes_ES
dc.subject.meshHospitalizationes_ES
dc.subject.meshHumanses_ES
dc.subject.meshLong-Term Carees_ES
dc.subject.meshPandemicses_ES
dc.subject.meshRNA, Messengeres_ES
dc.subject.meshSARS-CoV-2es_ES
dc.subject.meshSpaines_ES
dc.titleEffectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021es_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicatione177bf8c-3734-480b-a2ae-4ae67491776c
relation.isAuthorOfPublicationa0bb4f4f-11f0-487e-bf93-0b13f90057cc
relation.isAuthorOfPublicationb9db5b2d-44c4-4d09-8de8-781466b510e3
relation.isAuthorOfPublication31b0c6a2-7ad7-4c65-ac8a-d9b8762bcbee
relation.isAuthorOfPublicatione77e1f2d-b4e2-4ba5-a853-c2795850dcae
relation.isAuthorOfPublication.latestForDiscoverye177bf8c-3734-480b-a2ae-4ae67491776c
relation.isPublisherOfPublication844b1441-479c-4219-87e5-efc493160a02
relation.isPublisherOfPublication.latestForDiscovery844b1441-479c-4219-87e5-efc493160a02

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
EffectivenessOfMRNACOVID_2021.pdf
Size:
292.83 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Centro Nacional de Epidemiología (CNE)